BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26722437)

  • 1. UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.
    Jin Y; Zhang W; Xu J; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Int J Clin Exp Pathol; 2015; 8(10):12500-8. PubMed ID: 26722437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of ubiquitin carboxy terminal hydrolase-L1 induces apoptosis in breast cancer cells.
    Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
    Int J Oncol; 2008 Nov; 33(5):1037-45. PubMed ID: 18949367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ubiquitin carboxyl terminal hydrolase-L1 enhances multidrug resistance and invasion/metastasis in breast cancer by activating the MAPK/Erk signaling pathway.
    Wang W; Zou L; Zhou D; Zhou Z; Tang F; Xu Z; Liu X
    Mol Carcinog; 2016 Sep; 55(9):1329-42. PubMed ID: 26293643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.
    Jin Y; Zhang W; Wang H; Zhang Z; Chu C; Liu X; Zou Q
    Oncol Rep; 2016 Feb; 35(2):771-8. PubMed ID: 26718028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between CD147 and P-glycoprotein and their regulation by ubiquitination in breast cancer cells.
    Wang WJ; Li QQ; Xu JD; Cao XX; Li HX; Tang F; Chen Q; Yang JM; Xu ZD; Liu XP
    Chemotherapy; 2008; 54(4):291-301. PubMed ID: 18689982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCH-L1-containing exosomes mediate chemotherapeutic resistance transfer in breast cancer.
    Ning K; Wang T; Sun X; Zhang P; Chen Y; Jin J; Hua D
    J Surg Oncol; 2017 Jun; 115(8):932-940. PubMed ID: 28334432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.
    Schröder C; Milde-Langosch K; Gebauer F; Schmid K; Mueller V; Wirtz RM; Meyer-Schwesinger C; Schlüter H; Sauter G; Schumacher U
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1745-55. PubMed ID: 23996067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.
    Chen XS; Wang KS; Guo W; Li LY; Yu P; Sun XY; Wang HY; Guan YD; Tao YG; Ding BN; Yin MZ; Ren XC; Zhang Y; Chen CS; Ye YC; Yang JM; Cheng Y
    Theranostics; 2020; 10(4):1833-1848. PubMed ID: 32042339
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of EGFR in the promotion of malignant properties in multidrug resistant breast cancer cells.
    Xu JW; Li QQ; Tao LL; Cheng YY; Yu J; Chen Q; Liu XP; Xu ZD
    Int J Oncol; 2011 Dec; 39(6):1501-9. PubMed ID: 21805028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.
    Lien HC; Wang CC; Lin CH; Lu YS; Huang CS; Hsiao LP; Yao YT
    Hum Pathol; 2013 Sep; 44(9):1838-48. PubMed ID: 23664488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
    Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
    Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
    Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
    J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.
    Luo Y; He J; Yang C; Orange M; Ren X; Blair N; Tan T; Yang JM; Zhu H
    J Cell Biochem; 2018 Jan; 119(1):691-700. PubMed ID: 28636190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin C-terminal hydrolase-L1 increases cancer cell invasion by modulating hydrogen peroxide generated via NADPH oxidase 4.
    Kim HJ; Magesh V; Lee JJ; Kim S; Knaus UG; Lee KJ
    Oncotarget; 2015 Jun; 6(18):16287-303. PubMed ID: 25915537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1.
    Manago Y; Kanahori Y; Shimada A; Sato A; Amano T; Sato-Sano Y; Setsuie R; Sakurai M; Aoki S; Wang YL; Osaka H; Wada K; Noda M
    J Neurochem; 2005 Mar; 92(5):1061-72. PubMed ID: 15715657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
    Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
    Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
    Miyoshi Y; Nakayama S; Torikoshi Y; Tanaka S; Ishihara H; Taguchi T; Tamaki Y; Noguchi S
    Cancer Sci; 2006 Jun; 97(6):523-9. PubMed ID: 16734731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-arrestin 2 is associated with multidrug resistance in breast cancer cells through regulating MDR1 gene expression.
    Jing X; Zhang H; Hu J; Su P; Zhang W; Jia M; Cheng H; Li W; Zhou G
    Int J Clin Exp Pathol; 2015; 8(2):1354-63. PubMed ID: 25973019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin C-terminal hydrolase-L1 (Uch-L1) correlates with gonadal transformation in the rice field eel.
    Sun J; Shang X; Tian Y; Zhao W; He Y; Chen K; Cheng H; Zhou R
    FEBS J; 2008 Jan; 275(2):242-9. PubMed ID: 18076650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
    Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
    Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.